Novo Holdings

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.

Sibel Arnes

Associate

Nis Bjørnholt Bak

Principal

Jeroen Bakker

Partner, Seed Investments

Scott Beardsley

Managing Partner

Raymond Camahort

Principal at Novo Ventures

Lily Chang

Vice President, Growth Investments

Kartik Dharmadhikari

Partner, Bioindustrial Investments

Thomas Dyrberg

Partner

Morten Graugaard Døssing

Investment Director

Aleks Engel

Partner, Novo Holdings (Novo Seeds) and Director, REPAIR Impact Fund

Anna Fan

Senior Partner, Life Sciences Operating Committee, Venture Investments, Venture Investments (US) Inc

Thomas Grotkjær

Investor and Principal

Kenneth Harrison Ph.D

Senior Partner

Kuang He Ph.D

Vice President, Seed Investments

Stephen van Helden

Principal, Bioindustrial Investments, Growth Investments

Deepa Hingorani

Partner, Planetary Health Investments

Karen Hong

Partner, Novo Ventures (US) Inc

Johan Hueffer

Senior Partner, Principal Investments

Amit Kakar

Managing Partner and Head of Novo Holdings Asia

Navjeewan Khosla

Partner, Novo Holdings Equity Asia

Max Klement

Principal, Venture Investments

Nilesh Kumar

Senior Principal

Kasim Kutay

CEO

Abhijeet Lele

Senior Partner and Head of US Principal Investments

Jeffrey Low, MD

Principal

Heather Ludvigsen

Senior Manager, Venture Investments

Nanna Lüneborg

Principal

Joseph Markson Ph.D

Principal, Venture Investments

Peter Moldt

Partner

Daniel O'Connell

Partner, Venture Investments

Daniel Rasmussen

Principal, Seed Investments

Naveed Siddiqi

Senior Partner, Venture Investments

Eric Snyder

Partner, Venture Investments

Jim Trenkle

Partner, Venture Investments

Past deals in Dietary Supplements

Sylvan

Private Equity Round in 2025
Sylvan Inc. is a biotechnology company that specializes in the production and distribution of mushroom spawns, including agaricus, pleurotus, shiitake, and casing inoculum. Established in 1946 and based in Kittanning, Pennsylvania, Sylvan operates production and sales facilities across multiple countries, including the Netherlands, France, Hungary, Ireland, South Africa, Australia, and various locations in the United States. The company also provides disease control products for mushrooms, nutritional supplements, and nicolon nets. In addition to its production capabilities, Sylvan supports the food, health, agriculture, and materials industries through solid-state fermentation technology. The company emphasizes a collaborative approach to innovation and value creation in fungal biotechnology. As of 2019, Sylvan operates as a subsidiary of Jiangsu Yuguan Modern Agricultural S&T Co., Ltd.

Elo Life Systems

Series A in 2024
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to connect food, agriculture, and health by addressing challenges related to agricultural productivity, nutritional needs, food security, and overall wellness. Elo employs advanced techniques such as precision breeding, genomics, data analytics, and machine learning to develop healthier food alternatives. By focusing on replacing sugar and artificial sweeteners, Elo strives to empower consumers to enjoy their favorite foods while leading healthier lives. Through strategic partnerships within the food systems value chain, the company seeks to create sustainable solutions that benefit both individuals and communities.

Elo Life Systems

Series A in 2023
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to connect food, agriculture, and health by addressing challenges related to agricultural productivity, nutritional needs, food security, and overall wellness. Elo employs advanced techniques such as precision breeding, genomics, data analytics, and machine learning to develop healthier food alternatives. By focusing on replacing sugar and artificial sweeteners, Elo strives to empower consumers to enjoy their favorite foods while leading healthier lives. Through strategic partnerships within the food systems value chain, the company seeks to create sustainable solutions that benefit both individuals and communities.

Kate Farms

Series C in 2022
Kate Farms, Inc. is a company that specializes in producing vegan meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing plant-based formulas that are easy to digest and made from organic ingredients. These products are designed to provide nutrition without common allergens or synthetic additives, making them suitable for individuals with various dietary restrictions and medical conditions. Kate Farms' offerings are available through both prescription and over-the-counter channels, and the company serves a wide range of patients, from those with severe chronic diseases to those with less serious health issues. Its products are distributed through a network of retail stores across the United States and online.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.